Skip to content
Precision for Medicine
Category Hero Image category_03_01

Target Validation, Biomarker Validation, and Safety

Effective validation of therapeutic targets and biomarkers

Precision for Medicine, with a specific focus on histopathology and access to diverse biospecimens, provides a range of human tissue–based research services from the preclinical to clinical stages of development. We specialize in various programs involving small molecule, large molecule, and advanced therapeutics (gene and cell therapies). Our expertise in genomics and cell biology supports you in understanding target expression and localization, determining tumor biology and cellular interplay, and characterizing novel therapeutic entities.

Precision’s technologies providing biomarker and safety insight

  • Explore

    Target Expression

    Using a proprietary qRT-PCR-based platform, whole body target expression data supports target validation, drug repurposing, evaluation of potential clinical safety concerns, and validation of animal models.
    Explore

    Target Expression

    Using a proprietary qRT-PCR-based platform, whole body target expression data supports target validation, drug repurposing, evaluation of potential clinical safety concerns, and validation of animal models.
    Explore
  • Explore

    Cell-Based Assays

    Developing and qualifying 2D and 3D human in vitro cell-based models, using a broad range of human primary cell types. These models are further utilized in bioassays, with the analysis enabling a variety of endpoints.
    Explore

    Cell-Based Assays

    Developing and qualifying 2D and 3D human in vitro cell-based models, using a broad range of human primary cell types. These models are further utilized in bioassays, with the analysis enabling a variety of endpoints.
    Explore
  • Explore
    fish-ish_card-thumbnail

    Fluorescence In Situ Hybridization (FISH)/ISH

    Development of multiplex FISH/ISH assays to detect abnormalities in a range of tissues, including hematological and solid organ tumors.
    Explore

    Fluorescence In Situ Hybridization (FISH)/ISH

    Development of multiplex FISH/ISH assays to detect abnormalities in a range of tissues, including hematological and solid organ tumors.
    Explore
  • Explore
    Multiplex

    Multiplex immunofluorescence (mIF)

    Automated multiplex immunofluorescence services that enable quantitative visualization of up to 9 markers in tissue and liquid biopsies.
    Explore

    Multiplex immunofluorescence (mIF)

    Automated multiplex immunofluorescence services that enable quantitative visualization of up to 9 markers in tissue and liquid biopsies.
    Explore
  • Explore
    IHC
    tissue-slide

    lmmunohistochemistry (IHC)

    End-to-end IHC solutions including kitting, sample logistics, staining via all major platforms, and in-house pathology services.
    Explore
    tissue-slide

    lmmunohistochemistry (IHC)

    End-to-end IHC solutions including kitting, sample logistics, staining via all major platforms, and in-house pathology services.
    Explore
  • Explore
    tissue-cross-reactivity_header
    tissue

    Tissue Biospecimens

    Thousands of IRB-approved, clinically annotated biospecimens, including samples characterized via next-generation sequencing (NGS), are available to help researchers optimize biomarker and diagnostic development. These are ready to ship the same day to your lab.
    Explore
    tissue

    Tissue Biospecimens

    Thousands of IRB-approved, clinically annotated biospecimens, including samples characterized via next-generation sequencing (NGS), are available to help researchers optimize biomarker and diagnostic development. These are ready to ship the same day to your lab.
    Explore

Histopathology labs supporting beyond target and biomarker validation

Precision’s histopathology labs offer comprehensive services for target and biomarker validation. Our team of board-certified pathologists specialize in various areas of clinical research, including companion diagnostics development, and in vitro diagnostics (IVD) development.

  • iStock-1370585977

    Winston-Salem, North Carolina, US

    IHC/mIF Stainers & Scanners

    • Dako Autostainer Link 48
    • Dako PT Link
    • Leica Bond II
    • Ventana BenchMark ULTRA
    • Aperio GT 450
    • 3DHISTECH


    Certifications

    • CAP/CLIA
    • ISO 9001:2005
  • iStock-1130924353

    Houston, Texas, US

    IHC/mIF Stainers & Scanners

    • Leica Bond RX
    • Akoya Vectra Polaris
    • Aperio GT 450
    • InForm / HALO AP
    • Halo/AI


    Certifications

    • CLIA
    • GxP
  • iStock-980627542

    Royston, UK

    IHC/mIF Stainers & Scanners

    • Leica Bond RX
    • Dako Autostainer + PT Link
    • Ventana Discovery ULTRA 
    • Aperio AT2
    • Akoya Vectra Polaris
    • InForm / HALO AP


    Certifications

    • GLP
    • GCLP

Journey of a
Therapeutic Antibody:
From Preclinical to
Clinical Proof of Concept

Gain comprehensive insights into the process of developing therapeutic antibodies from discovery to clinical success.

eBook

Journey of a Therapeutic Antibody: Preclinical to Clinical Proof of Concept

Download eBook
Journey of a Therapeutic Antibody: Preclinical to Clinical Proof of Concept

Approaches for target and biomarker validation, and for therapeutic characterization

Precision’s target and biomarker validation and safety services include consultative study design and assay development, analysis and interpretation of data, and data reporting.

target validation vert-1

Explore Precision’s other specialty assay areas

  • Explore
    AdobeStock_171759632
    Immune-monitoring

    Immune Monitoring

    Leverage sophisticated immune monitoring approaches, including flow cytometry, Epiontis ID® immune cell phenotyping, and cytokine profiling, to characterize the immune cells in your samples and understand their impact on patient biology.

    Explore
    Immune-monitoring

    Immune Monitoring

    Leverage sophisticated immune monitoring approaches, including flow cytometry, Epiontis ID® immune cell phenotyping, and cytokine profiling, to characterize the immune cells in your samples and understand their impact on patient biology.

    Explore
  • Explore
    AdobeStock_150933051
    Bioanalytical

    Bioanalytical Testing

    At Precision, we understand the complexities of immunogenicity testing and other bioanalytical methods, with a leadership team that continues to shape and inform regulatory guidance. 

    Explore
    Bioanalytical

    Bioanalytical Testing

    At Precision, we understand the complexities of immunogenicity testing and other bioanalytical methods, with a leadership team that continues to shape and inform regulatory guidance. 

    Explore
  • Explore
    AdobeStock_170266737

    Tissue Biopsy Analysis

    At Precision for Medicine, we’re committed to delivering gold-standard tissue sourcing, processing, and analysis services.

    Explore

    Tissue Biopsy Analysis

    At Precision for Medicine, we’re committed to delivering gold-standard tissue sourcing, processing, and analysis services.

    Explore

Discover the Precision blog

Read our blog to gain more insights and discover work that Precision has supported.

Read: Back to the Source: A Translational Leader on Extending the Living Legacy of Genomic Data Back to the Source: A Translational Leader on Extending the Living Legacy of Genomic Data

Translational Research - Biospecimens - Oncology

Back to the Source: A Translational Leader on Extending the Living Legacy of Genomic Data

|
    has not third author: true, (SizeLimitingPyMap: {main={hs_id=159488778886, hs_child_table_id=0, hs_updated_at=1763657611624, hs_published_at=1763745278294, description=Robert Snyder, PhD, is a seasoned expert with a 20-year track record in genomics, specializing in in vitro diagnostic assay development and bioinformatics. Committed to advancing medical science, he is proficient in regulatory V&V study designs and understands the nuances of orthogonal methods. A collaborative partner in biomedical development, Dr. Snyder champions the critical transition of biospecimens from benchtop to bedside., avatar=Image{width=576,height=576,url='https://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/PfM%20Website/Headshots/Headshots%20no%20background/Robert%20Snyder.webp',altText='Robert Snyder',fileId=165892444501}, linkedin=https://www.linkedin.com/in/robert-snyder-ph-d-9b67b035, hs_name=, hs_path=, lastname=Snyder, PhD, hs_initial_published_at=1763062961222, hs_created_at=1709645745117, hs_is_edited=false, hs_deleted_at=0, name=Robert, job=, slug=robert-snyder, email=, hs_updated_by_user_id=26433386}, second={hs_id=164691024166, hs_child_table_id=0, hs_updated_at=1716326265678, hs_published_at=1763745278294, description=Respected veteran of the biospecimen and biomarker laboratory services industry. Honed his expertise through leadership roles in organizations including Roche, Cancer Genetics, and BioServe. Holds a Master of Public Health and a Masters of Business Administration from the Johns Hopkins University., avatar=Image{width=576,height=576,url='https://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/PfM%20Website/Headshots/Headshots%20no%20background/Rob%20Fannon%20Headshot.webp',altText='Rob Fannon Headshot',fileId=165893006477}, linkedin=https://www.linkedin.com/in/rob-fannon-901378/, team=[{id=163072475009, name='Translational Sciences Leadership'}], lastname=Fannon, MPH, MBA, hs_initial_published_at=1713346931329, hs_created_by_user_id=62155952, hs_created_at=1713345787919, hs_is_edited=false, hs_deleted_at=0, name=Rob, job=General Manager, Biospecimen Solutions, slug=rob-fannon, hs_updated_by_user_id=26433386}, third={}})
  • Robert S. avatar

    Robert S.

  • Rob F. avatar

    Rob F.

Discover
Read: Reflect on 20 Years of Cancer Research with MIRROR Biospecimens Reflect on 20 Years of Cancer Research with MIRROR Biospecimens

Translational Research - Biospecimens

Reflect on 20 Years of Cancer Research with MIRROR Biospecimens

|
    has not third author: true, (SizeLimitingPyMap: {main={hs_id=199448088864, hs_child_table_id=0, hs_updated_at=1762810484868, hs_published_at=1763745278294, avatar=Image{width=1200,height=1200,url='https://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Kaylee%20Mueller.png',altText='Kaylee Mueller',fileId=199456336149}, lastname=Mueller, hs_initial_published_at=1762810487482, hs_created_by_user_id=26433386, hs_created_at=1762810467146, hs_is_edited=false, hs_deleted_at=0, name=Kaylee, slug=kaylee-mueller, hs_updated_by_user_id=26433386}, second={}, third={}})
  • Kaylee Mueller avatar

    Kaylee Mueller

Discover
Read: Lost in Translation: Turning Multi-omic Chaos into Clinical Clarity Lost in Translation: Turning Multi-omic Chaos into Clinical Clarity

Translational Research - Lab Services

Lost in Translation: Turning Multi-omic Chaos into Clinical Clarity

|
    has third author: false, (SizeLimitingPyMap: {main={hs_id=159488778872, hs_child_table_id=0, hs_updated_at=1744653337128, hs_published_at=1763745278294, description=Visionary leader with decades of distinguished biotechnology and clinical translational research experience. Founded ApoCell in 2004 and later was instrumental in developing and commercializing the ApoStream® rare-cell liquid biopsy technology. Globally recognized cancer researcher and the author of more than 100 peer-reviewed publications. Dedicated and committed to improving the lives of patients with debilitating diseases., avatar=Image{width=576,height=576,url='https://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/PfM%20Website/Headshots/Headshots%20no%20background/Darren%20Davis.webp',altText='Darren Davis',fileId=165891429693}, linkedin=https://www.linkedin.com/in/drdarrendavis, team=[{id=163072475009, name='Translational Sciences Leadership'}], hs_name=, hs_path=, lastname=Davis, PhD, hs_initial_published_at=1763062961222, hs_created_at=1709645745103, hs_is_edited=false, hs_deleted_at=0, name=Darren, job=Senior Vice President, Translational Sciences, slug=darren-davis, email=, hs_updated_by_user_id=26433386}, second={hs_id=167888548278, hs_child_table_id=0, hs_updated_at=1722451546286, hs_published_at=1763745278294, description=Pharma industry veteran and expert at biomarker-driven clinical trial design and execution. Leader of biomarker and drug development programs for pharmaceutical and diagnostics companies, as well as the National Institutes of Health. Spearheaded the discovery of pharmacodynamic biomarkers and novel targets for inflammatory disease therapy., avatar=Image{width=576,height=576,url='https://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/PfM%20Website/Headshots/Headshots%20no%20background/Deb%20Phippard.webp',altText='Deb Phippard',fileId=165892372605}, linkedin=https://www.linkedin.com/in/deb-phippard-103b54, team=[{id=163072475009, name='Translational Sciences Leadership'}], hs_name=, hs_path=, lastname=Phippard, PhD, hs_initial_published_at=1716194887110, hs_created_by_user_id=2737751, hs_created_at=1716194842710, hs_is_edited=false, hs_deleted_at=0, name=Deborah, job=Chief Scientific Officer, slug=deborah-phippard-translational-sciences, email=, hs_updated_by_user_id=26433386}, third={hs_id=159488778886, hs_child_table_id=0, hs_updated_at=1763657611624, hs_published_at=1763745278294, description=Robert Snyder, PhD, is a seasoned expert with a 20-year track record in genomics, specializing in in vitro diagnostic assay development and bioinformatics. Committed to advancing medical science, he is proficient in regulatory V&V study designs and understands the nuances of orthogonal methods. A collaborative partner in biomedical development, Dr. Snyder champions the critical transition of biospecimens from benchtop to bedside., avatar=Image{width=576,height=576,url='https://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/PfM%20Website/Headshots/Headshots%20no%20background/Robert%20Snyder.webp',altText='Robert Snyder',fileId=165892444501}, linkedin=https://www.linkedin.com/in/robert-snyder-ph-d-9b67b035, hs_name=, hs_path=, lastname=Snyder, PhD, hs_initial_published_at=1763062961222, hs_created_at=1709645745117, hs_is_edited=false, hs_deleted_at=0, name=Robert, job=, slug=robert-snyder, email=, hs_updated_by_user_id=26433386}})
  • Darren D. avatar Deborah P. avatar Robert S. avatar
  • Darren D.

    Deborah P.

    Robert S.

Discover

View some of Precision’s available biospecimens products